Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Satoshi Kameshima has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dapagliflozin inhibits TGF-β-induced transdifferentiation of valvular interstitial cells and mitral valvular degeneration

    by Remi Sato, Kosei Sakai, Satoshi Kameshima

    Myxomatous mitral valve (MV) disease (MMVD) is a common cardiac condition in humans and dogs. Currently, no therapeutic agent is available for MMVD that can prevent MV degeneration. Transforming growth factor (TGF)-β-induced transdifferentiation of valvular interstitial cells (VICs) is a key process in MV degeneration. Dapagliflozin is used to treat type 2 diabetes, and it alleviates cardiac and renal fibrosis by inhibiting the TGF-β signaling pathway. In this study, we investigated the effect of dapagliflozin on TGF-β-induced transdifferentiation of VICs and MV degeneration in rats. Protein expression levels and contractile forces generated by VICs were determined using western blotting and a collagen gel contraction assay, respectively. Structural changes of the MV were detected using histological staining. Dapagliflozin inhibited TGF-β-induced Smad2/3 phosphorylation and increased alpha-smooth muscle actin expression and the cellular contractile force. In contrast, dapagliflozin increased the activity of adenosine monophosphate-activated protein kinase (AMPK)α. However, 5-aminoimidazole-4-carboxamide 1-β-D-ribofuranoside, an AMPK activator, inhibited TGF-β-induced Smad2/3 phosphorylation. AMPKα gene knockdown impeded the inhibitory effect exerted by dapagliflozin on TGF-β-induced Smad2 phosphorylation. Additionally, dapagliflozin increased AMPKα phosphorylation and suppressed TGF-β-induced MV degeneration, alpha-smooth muscle actin expression, and Smad2/3 phosphorylation in isolated rat MV. To the best of our knowledge, this study is the first to demonstrate that dapagliflozin inhibits TGF-β-induced VIC differentiation and subsequent MV degeneration by suppressing Smad signaling via AMPK activation, suggesting that dapagliflozin is a potential novel therapeutic agent for MMVD. Key messages: TGF-β-induced VIC differentiation leads to MV degeneration. DAPA, an SGLT2 inhibitor, suppresses the TGF-β signaling pathway. DAPA inhibits TGF-β-induced differentiation of rat VIC via AMPK activation. DAPA inhibits TGF-β-induced degeneration and signal transduction in isolated rat MV. DAPA suppresses MV degeneration by inhibiting VIC differentiation.


  • Open Access

    Volatile Sulfur Compounds Produced by the Anaerobic Bacteria Porphyromonas spp. Isolated from the Oral Cavities of Dogs

    by Noriyuki Ito, Naoyuki Itoh, Satoshi Kameshima

    Porphyromonas spp. are oral anaerobic Gram-negative bacteria that form black-pigmented colonies on blood agar and produce volatile sulfur compounds (VSCs), such as hydrogen sulfide (H2S), methyl mercaptan (CH3SH), and dimethyl sulfide ((CH3)2S), which cause halitosis and the destruction of periodontal tissues. P. gulae is considered the main pathogen involved in periodontal disease in dogs. However, the characteristics of the VSCs produced by P. gulae are unknown. In the present study, VSCs were measured in 26 isolates of P. gulae and some isolates of the other Porphyromonas spp. obtained from the oral cavities of dogs with periodontal disease using an in vitro assay with an Oral ChromaTM gas chromatograph. The results demonstrated that P. gulae was able to produce large amounts of H2S and CH3SH, and the dominant product was CH3SH (CH3SH/H2S was approximately 2.2). Other Porphyromonas spp. that were also obtained from the oral cavities of dogs with periodontal disease indicated similar levels of production of H2S and CH3SH to those of P. gulae. It is strongly suggested that the high levels of H2S and CH3SH produced by P. gulae and other Porphyromonas spp. contribute to halitosis and the destruction of periodontal tissues during the progression of periodontal disease in dogs.


  • Open Access

    Male pseudohermaphroditism in a complex malformed calf born with an acardius amorphus cotwin—a case report

    by Hiromi Kusaka, Makoto Sugiyama, Satoshi Kameshima, Takehiko Kakizaki, Yasunori Suzuki, Ryo Ando, Hiroshi Miura, Motohiro Kikuchi, Hiroaki Kawaguchi, Minoru Sakaguchi

    Background: Male pseudohermaphroditism is a developmental anomaly wherein animals are genetically and gonadally male, but their internal and/or external genitalia resemble those of females. In cattle, pseudohermaphroditism is often accompanied by multiple severe malformations. To the best of our knowledge, this is the first report of male pseudohermaphroditism in a complex malformed calf born with an acardius amorphous cotwin. Case presentation: This report describes the case of a three-day-old, male anurous Japanese Black calf born with an acardius amorphous cotwin, complete absence of the tail, agenesis of the anus, separate scrota, and umbilical hernia. Transthoracic echocardiography and computed tomography revealed serious malformations in the skeletal system and the circulatory, digestive, urinary, and genital organs. Necropsy revealed rectal atresia, immature testes, epididymis, and penis, but no male accessory gonads. Histological analyses revealed vaginal- and uterine-like tissues adjacent to or fused to the rectum. Fluorescence in situ hybridization detected X and Y chromosomes, and some cells presented two X-probe signals in the same nucleus. Conclusions: In contrast to the male genitalia, the female genitalia derived from the Müllerian ducts were difficult to detect by necropsy in the presented case. Many similar cases may be overlooked in clinical practice.


  • Open Access

    Volatile Sulfur Compounds Produced by the Anaerobic Bacteria Porphyromonas spp. Isolated from the Oral Cavities of Dogs

    by Noriyuki Ito, Naoyuki Itoh, Satoshi Kameshima

    Porphyromonas spp. are oral anaerobic Gram-negative bacteria that form black-pigmented colonies on blood agar and produce volatile sulfur compounds (VSCs), such as hydrogen sulfide (H2S), methyl mercaptan (CH3SH), and dimethyl sulfide ((CH3)2S), which cause halitosis and the destruction of periodontal tissues. P. gulae is considered the main pathogen involved in periodontal disease in dogs. However, the characteristics of the VSCs produced by P. gulae are unknown. In the present study, VSCs were measured in 26 isolates of P. gulae and some isolates of the other Porphyromonas spp. obtained from the oral cavities of dogs with periodontal disease using an in vitro assay with an Oral ChromaTM gas chromatograph. The results demonstrated that P. gulae was able to produce large amounts of H2S and CH3SH, and the dominant one was CH3SH (CH3SH/H2S was approximately 2.2). Other Porphyromonas spp. that were also obtained from the oral cavities of dogs with periodontal disease indicated the similar levels of production of H2S and CH3SH to those of P. gulae. It is strongly suggested that the high levels of H2S and CH3SH in P. gulae and other Porphyromonas spp. contribute to halitosis and the destruction of periodontal tissues during the progression of periodontal disease in dogs.


  • Open Access

    Effects of a Soluble Guanylate Cyclase Stimulator Riociguat on Contractility of Isolated Pulmonary Artery and Hemodynamics of U46619-Induced Pulmonary Hypertension in Dogs

    by Satoshi Kameshima, Yuki Nakamura, Kenji Uehara, Tomoko Kodama, Hideyuki Yamawaki, Kotaro Nishi, Shozo Okano, Ryo Niijima, Yuya Kimura, Naoyuki Itoh

    Soluble guanylate cyclase (sGC) stimulator riociguat is a relatively novel therapeutic agent for pulmonary hypertension (PH) in human medicine. Riociguat induces endothelium-independent pulmonary artery (PA) relaxation by directly activating the sGC-cyclic guanosine-3′,5′-monophosphate (cGMP) pathway in muscle cells. Although riociguat may be effective in the treatment of dogs with refractory PH, basic studies on its clinical application in veterinary medicine are lacking. The present study aimed to explore the effects of riociguat on the contractility of an isolated canine PA and the hemodynamics of dogs with acute PH. In an isolated endothelium-denuded canine PA, the effects of riociguat on endothelin (ET)-1-induced contraction and cGMP levels were investigated using the Magnus method and ELISA, respectively. The effect of riociguat on the hemodynamics of the thromboxane A2 analog U46619-induced PH model dog was examined by invasive catheterization. Riociguat increased cGMP levels and reduced ET-1-induced contraction of the isolated PA. Riociguat inhibited the U46619-induced elevation of PA pressure and pulmonary vascular resistance and increased cardiac output, but it had no effect on basal systemic blood pressure. These results demonstrate for the first time that riociguat can inhibit the elevation of PA pressure through PA relaxation via an endothelium-independent increase in cGMP in dogs with PH.


  • Open Access

    Human Omentin-1 Administration Ameliorates Hypertensive Complications without Affecting Hypertension in Spontaneously Hypertensive Rats

    by Yuta Okamura, Ryo Niijima, Satoshi Kameshima, Tomoko Kodama, Kosuke Otani, Muneyoshi Okada, Hideyuki Yamawaki

    Hypertension is one of the major risk factors for cardiovascular diseases and is caused by various abnormalities including the contractility of blood vessels. Spontaneously hypertensive rats (SHR), whose systemic blood pressure increases with aging, are a frequently used animal model for investigating essential hypertension and related complications in humans due to the damage of several organs. Human omentin-1 is an adipocytokine consisting of 313 amino acids. Serum omentin-1 levels decreased in hypertensive patients compared with normotensive controls. Furthermore, omentin-1 knockout mice showed elevated blood pressure and impaired endothelial vasodilation. Taken together, we hypothesized that adipocytokine, human omentin-1 may improve the hypertension and its complications including heart and renal failure in the aged SHR (65–68-weeks-old). SHR were subcutaneously administered with human omentin-1 (18 μg/kg/day, 2 weeks). Human omentin-1 had no effect on body weight, heart rate, and systolic blood pressure in SHR. The measurement of isometric contraction revealed that human omentin-1 had no influence on the enhanced vasocontractile or impaired vasodilator responses in the isolated thoracic aorta from SHR. On the other hand, human omentin-1 tended to improve left ventricular diastolic failure and renal failure in SHR. In summary, human omentin-1 tended to improve hypertensive complications (heart and renal failure), while it had no influence on the severe hypertension in the aged SHR. The further study of human omentin-1 may lead to the development of therapeutic agents for hypertensive complications.


  • Open Access

    Molecular Determination of Zoonotic Microsporidia from Feral Pigeon (Columba livia) in Japan

    by Naoyuki Itoh, Satoshi Kameshima, Yuya Kimura

    千葉県と長野県のカワラバトの糞便 108 検体中 6 検体から,人獣共通感染性の微胞子虫(Microsporidia)Encephalitozoon属微胞子虫が検出され(5.6%),E. hellemが 1 例(0.9%),E. cuniculiが 3 例(2.8%),E. hellem E. cuniculiの混合感染は 2 例だった(1.9%)。シークエンス解析の結果,E. hellemはgenotype 2B,E. cuniculiは genotype Ⅲに分類され,いずれもヒトから検出されている遺伝子型だった。今回,国内のカワラバトから初めて微胞子虫を検出したが,ヒトの微胞子虫感染のレゼルボアとなる可能性は低いと推測された。

  • Open Access

    Clinical efficacy of combination therapy of itraconazole and prednisolone for treating effusive feline infectious peritonitis

    by Satoshi Kameshima, Yuya Kimura, Tomoyoshi Doki, Tomomi Takano, Chun-Ho Park, Naoyuki Itoh

    A 3-month-old male Scottish Fold kitten with pleural fluid and low ratio of albumin to globulin (A/G ratio) was brought to our small animal hospital. Since RNA from the type I feline coronavirus (FCoV) were detected in drained pleural fluid, the cat was tentatively diagnosed with effusive feline infectious peritonitis (FIP). Following the administration of itraconazole and prednisolone, the A/G ratio increased, and the pleural fluid mostly disappeared. The fecal FCoV levels temporarily decreased. However, the cat showed neurological manifestations and was eventually euthanized due to status epilepticus after 38 days of treatment. In conclusion, itraconazole partly exerted a beneficial effect in a cat with FIP. However, further investigation of a possible role of itraconazole in FIP treatment is warranted.


  • Open Access

    Acute intracerebroventricular injection of chemerin-9 increases systemic blood pressure via CMKLR1 in rats

    by Yamamoto Atsunori, Kengo Matsumoto, Satoshi Kameshima, Naoko Yamaguchi, Syousirou Okada, Muneyoshi Okada, Hideyuki Yamawaki

    Chemerin is an inflammatory adipocytokine through acting on G protein-coupled receptor, chemokine-like receptor (CMKLR)1. We previously demonstrated that long-term intraperitoneal administration with chemerin increased systolic blood pressure (BP) in mice. Since important nuclei regulating BP exist in the brain, we examined mechanisms of central BP control by chemerin-9.BP was invasively measured after acute intracerebroventricular (i.c.v.) injection of chemerin-9 to CMKLR1 siRNA-treated rats for 3 days. Serum adrenaline was measured by HPLC method. CMKLR1 expression in the brain tissues of spontaneously hypertensive rat (SHR) was examined by Western blotting.In the control siRNA-treated rats, chemerin-9 significantly increased mean BP, while it had no effect in the CMKLR1 siRNA-treated rats. Serum adrenaline level was increased by the acute i.c.v. injection of chemerin-9. CMKLR1 expression around brain ventricles from SHR was increased.We for the first time demonstrated that chemerin-9 stimulates the sympathetic nerves via CMKLR1 expressed around brain ventricles, which leads to an increase in BP. It is further suggested that chemerin/CMKLR1 in the central nerves plays an important role in essential hypertension.